Clinical and observational research has shown that GLP-1 medications are associated with reduced alcohol cravings, lower consumption, and decreased risk of alcohol-related disorders GLP-1 use is already widespread in the U.S
SGLT2 inhibitors and GLP-1 agonists should be used as early as possible in the diabetes course to provide the most cardiac benefit, Joanna Khatib, MBBS, an endocrinology fellow at Tulane University School of Medicine, told Healio
Fast, Effective Results: Experience 100% absorption and feel the benefits of vitamins, hydration, and nutrients quickly and safely
Optimizes oxygen transport in the blood
Semaglutide is currently not on the WADA Prohibited List, though GLP-1 agonists as a class have been added to the WADA Monitoring Program since 2024 as a step toward potential future inclusion